Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 405.37m
  • Volume: 0
  • RiskGrade: 348

Key dates

Dividend  
Latest XD Date n/a
Latest Pay Date n/a
   
Meetings  
AGM 19-Dec-2024
EGM n/a
GMs 18-Dec-2024
   
Announcements  
Trading announcement 10-Apr-2025
IMSs n/a
Drilling Report n/a
   
Results  
Final results 30-Sep-2024
Interim results 18-Mar-2025
Q1 Results 20-Nov-2024
Q2 Results 31-Mar-2022
Q3 Results 15-May-2024
Q4 Results 28-Sep-2023
Annual Report 21-Nov-2024
   
Year End n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

RENX Market Data

Currency UK Pounds
Share Price 9.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 405.37m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page